Cargando…
Sofosbuvir induces gene expression for promoting cell proliferation and migration of hepatocellular carcinoma cells
Direct-acting antivirals (DAAs) have achieved a sustained virological response (SVR) rate of 95–99% in treating HCV. Several studies suggested that treatment with sofosbuvir (SOF), one type of DAAs, may be associated with increased risk of developing HCC. The aim of this study is to investigate the...
Autores principales: | Tsai, Wei-Lun, Cheng, Jin-Shiung, Liu, Pei-Feng, Chang, Tsung-Hsien, Sun, Wei-Chih, Chen, Wen-Chi, Shu, Chih-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365546/ https://www.ncbi.nlm.nih.gov/pubmed/35833210 http://dx.doi.org/10.18632/aging.204170 |
Ejemplares similares
-
The MAP3K7-mTOR Axis Promotes the Proliferation and Malignancy of Hepatocellular Carcinoma Cells
por: Cheng, Jin-Shiung, et al.
Publicado: (2019) -
Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience
por: Tsai, Wei-Lun, et al.
Publicado: (2020) -
Association of ATG4B and Phosphorylated ATG4B Proteins with Tumorigenesis and Prognosis in Oral Squamous Cell Carcinoma
por: Liu, Pei-Feng, et al.
Publicado: (2019) -
Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2014) -
MiR‐552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression
por: Qu, Weiqing, et al.
Publicado: (2018)